Found: 12
Select item for more details and to access through your institution.
Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, n. 3, p. 290, doi. 10.1111/j.1463-1326.2006.00685.x
- By:
- Publication type:
- Article
Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 5, p. 568, doi. 10.1111/j.1463-1326.2006.00643.x
- By:
- Publication type:
- Article
Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 2, p. 180, doi. 10.1111/dme.13125
- By:
- Publication type:
- Article
Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with type 1 diabetes.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.
- Published in:
- Diabetic Medicine, 2006, v. 23, n. 5, p. 522, doi. 10.1111/j.1464-5491.2006.01839.x
- By:
- Publication type:
- Article
Treatment intensification with an insulin degludec ( IDeg)/insulin aspart ( IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 274, doi. 10.1111/dom.12609
- By:
- Publication type:
- Article
Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 9, p. 826, doi. 10.1111/dom.12097
- By:
- Publication type:
- Article
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 2, p. 175, doi. 10.1111/dom.12032
- By:
- Publication type:
- Article
Ionic Strength of Homogenizing Medium on Glutamic Dehydrogenase Activity of Tissues.∗†.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1957, v. 94, n. 1, p. 192, doi. 10.3181/00379727-94-22895
- By:
- Publication type:
- Article
Increasing inequality in ischaemic heart disease morbidity among employed men in Denmark 1981-1993: the need for a new preventive policy.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Prevalence proportion ratios: estimation and hypothesis testing.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
- Published in:
- 2012
- By:
- Publication type:
- journal article